Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia

Krishnan et al., Journal of Clinical Anesthesia, doi:10.1016/j.jclinane.2020.110005
Jul 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 20% Improvement Relative Risk HCQ for COVID-19  Krishnan et al.  LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 152 patients in the USA Lower mortality with HCQ (not stat. sig., p=0.48) c19hcq.org Krishnan et al., J. Clinical Anesthesia, Jul 2020 FavorsHCQ Favorscontrol 0 0.5 1 1.5 2+
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
 
*, now with p < 0.00000000001 from 417 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,800+ studies for 102 treatments. c19hcq.org
Retrospective 152 mechanically ventilated patients in the USA showing unadjusted lower mortality with vitamin C, vitamin D, HCQ, and zinc treatment, statistically significant only for vitamin C.
Although the 20% lower mortality is not statistically significant, it is consistent with the significant 26% lower mortality [22‑30%] from meta analysis of the 252 mortality results to date.
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
Study covers zinc, vitamin D, vitamin C, and HCQ.
risk of death, 20.4% lower, RR 0.80, p = 0.48, treatment 86 of 144 (59.7%), control 6 of 8 (75.0%), NNT 6.5.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Krishnan et al., 20 Jul 2020, retrospective, USA, peer-reviewed, 13 authors, dosage not specified.
This PaperHCQAll
Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia
Sandeep Krishnan, Kinjal Patel, Ronak Desai, Anupam Sule, Peter Paik, Ashley Miller, Alicia Barclay, Adam Cassella, Jon Lucaj, Yvonne Royster, Joffer Hakim, Zulfiqar Ahmed, Farhad Ghoddoussi
Journal of Clinical Anesthesia, doi:10.1016/j.jclinane.2020.110005
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
References
Huang, Wang, Li, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Richardson, Hirsch, Narasimhan, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA
Sandeep Krishnan A,B,C, Patel D,E, Desai D,E , Anupam Sule F,G, Paik, Miller et al., None
Zhou, Yu, Du, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet
{ 'indexed': {'date-parts': [[2024, 3, 5]], 'date-time': '2024-03-05T05:24:41Z', 'timestamp': 1709616281887}, 'reference-count': 5, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2020, 12, 1]], 'date-time': '2020-12-01T00:00:00Z', 'timestamp': 1606780800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 12]]}, 'DOI': '10.1016/j.jclinane.2020.110005', 'type': 'journal-article', 'created': {'date-parts': [[2020, 7, 20]], 'date-time': '2020-07-20T05:33:39Z', 'timestamp': 1595223219000}, 'page': '110005', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 39, 'title': 'Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the ' 'State of Michigan with SARS-CoV-2 pneumonia', 'prefix': '10.1016', 'volume': '67', 'author': [ {'given': 'Sandeep', 'family': 'Krishnan', 'sequence': 'first', 'affiliation': []}, {'given': 'Kinjal', 'family': 'Patel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ronak', 'family': 'Desai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anupam', 'family': 'Sule', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter', 'family': 'Paik', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ashley', 'family': 'Miller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alicia', 'family': 'Barclay', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adam', 'family': 'Cassella', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jon', 'family': 'Lucaj', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yvonne', 'family': 'Royster', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joffer', 'family': 'Hakim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zulfiqar', 'family': 'Ahmed', 'sequence': 'additional', 'affiliation': []}, {'given': 'Farhad', 'family': 'Ghoddoussi', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '10223', 'key': '10.1016/j.jclinane.2020.110005_bb0005', 'doi-asserted-by': 'crossref', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in ' 'Wuhan, China', 'volume': '395', 'author': 'Huang', 'year': '2020', 'journal-title': 'Lancet'}, {'key': '10.1016/j.jclinane.2020.110005_bb0010', 'author': 'Johns Hopkins University'}, { 'key': '10.1016/j.jclinane.2020.110005_bb0015', 'series-title': 'Clinical management of severe acute respiratory infection when novel ' 'coronavirus (2019-nCoV) infection is suspected: Interim guidance, ' '28January 2020', 'author': 'World Health Organization', 'year': '2020'}, { 'issue': '20', 'key': '10.1016/j.jclinane.2020.110005_bb0020', 'doi-asserted-by': 'crossref', 'first-page': '2052', 'DOI': '10.1001/jama.2020.6775', 'article-title': 'Presenting characteristics, comorbidities, and outcomes among 5700 ' 'patients hospitalized with COVID-19 in the New York City area', 'volume': '323', 'author': 'Richardson', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '10229', 'key': '10.1016/j.jclinane.2020.110005_bb0025', 'doi-asserted-by': 'crossref', 'first-page': '1054', 'DOI': '10.1016/S0140-6736(20)30566-3', 'article-title': 'Clinical course and risk factors for mortality of adult inpatients with ' 'COVID-19 in Wuhan, China: a retrospective cohort study', 'volume': '395', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Lancet'}], 'container-title': 'Journal of Clinical Anesthesia', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0952818020312022?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0952818020312022?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2020, 12, 10]], 'date-time': '2020-12-10T20:43:04Z', 'timestamp': 1607632984000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0952818020312022'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 12]]}, 'references-count': 5, 'alternative-id': ['S0952818020312022'], 'URL': 'http://dx.doi.org/10.1016/j.jclinane.2020.110005', 'relation': {}, 'ISSN': ['0952-8180'], 'subject': ['Anesthesiology and Pain Medicine'], 'container-title-short': 'Journal of Clinical Anesthesia', 'published': {'date-parts': [[2020, 12]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Clinical comorbidities, characteristics, and outcomes of mechanically ' 'ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Journal of Clinical Anesthesia', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.jclinane.2020.110005', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'simple-article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2020 Published by Elsevier Inc.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '110005'}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit